KIORA PHARMACEUTICALS INC (KPRX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$2.550.00%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · KPRX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||
| Revenues | — | — | 16.0 | 0.0 | — | 0.0 | 0.0 | 2.7 | 1.7 | 0.4 | 0.7 | — |
| Total Revenues | — | — | 16.0 | 0.0 | — | — | — | — | 1.7 | 0.4 | 0.7 | — |
| Operating Expenses & Income | ||||||||||||
| R&D Expenses | 9.9 | 10.8 | 7.8 | 4.0 | 3.4 | 5.4 | 3.6 | 5.4 | 8.1 | 10.3 | 8.4 | 2.7 |
| Operating Income | (12.8) | (12.8) | 4.5 | (12.6) | (12.3) | (14.2) | (6.9) | (7.0) | (10.8) | (14.6) | (13.3) | (8.4) |
| Earnings from Continuing Operations | ||||||||||||
| Interest Expense | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.9 |
| Interest & Investment Income | — | 0.9 | 1.3 | 0.2 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 |
| Net Interest Expenses | — | — | — | (0.2) | (0.0) | 0.0 | (0.0) | (0.1) | (0.1) | 0.0 | (0.0) | 1.9 |
| Other Non-Operating Income / Expenses | 0.5 | 0.7 | 1.1 | 0.2 | (1.4) | 0.3 | 0.0 | 0.1 | 0.1 | (0.0) | 0.0 | (1.7) |
| EBT, Incl. Unusual Items | (12.3) | (12.1) | 5.7 | (12.4) | (13.7) | (14.0) | 8.1 | 7.0 | 10.7 | 14.6 | (13.3) | (8.4) |
| Income Tax Expense | — | (1.3) | 2.1 | 0.1 | (0.1) | (0.2) | 0.0 | 0.1 | 0.1 | (1.3) | — | — |
| Net Income | ||||||||||||
| Minority Interest | — | — | — | — | — | — | — | — | — | (0.0) | (0.0) | 0.0 |
| Net Income | (0.2) | (10.8) | 3.6 | (0.0) | (13.6) | (13.8) | (6.9) | (7.1) | (10.8) | (13.2) | (13.3) | (8.4) |
| Per Share | ||||||||||||
| Basic EPS | (0.03) | (2.60) | 0.93 | (24.25) | (18.55) | (57.12) | (1.49) | — | — | — | — | — |
| Diluted EPS | (0.03) | (2.64) | 0.87 | (24.25) | (18.55) | (57.12) | (1.49) | — | — | — | — | — |
| Basic Weighted Avg Shares | 6.2 | 4.2 | 3.9 | 0.5 | 0.7 | 0.2 | 4.6 | — | — | — | — | — |
| Diluted Weighted Avg Shares | 6.2 | 4.1 | 4.1 | 0.5 | 0.7 | 0.2 | 4.6 | — | — | — | — | — |
| Supplemental | ||||||||||||
| EBITDA | — | (12.8) | 4.5 | (12.5) | (12.3) | (14.2) | (6.8) | (6.9) | (10.8) | (14.5) | (13.3) | (8.4) |
| EBIT | (12.8) | (12.8) | 4.5 | (12.6) | (12.3) | (14.2) | (6.9) | (7.0) | (10.8) | (14.6) | (13.3) | (8.4) |
| Effective Tax Rate | — | — | — | -0.7% | 0.8% | 1.4% | 0.1% | 1.4% | 0.8% | -9.2% | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.